Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Regul Toxicol Pharmacol ; 131: 105146, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35219763

RESUMO

On October 21-22, 2020 the HESI (Health and Environmental Sciences Institute) Protein Allergens, Toxins, and Bioinformatics Committee, and the Society of Toxicology Food Safety Specialty Section co-hosted a virtual workshop titled "From Protein Toxins to Applied Toxicological Testing". The workshop focused on the safety assessment of novel proteins contained in foods and feeds, was globally represented by over 200 stakeholder attendees, and featured contributions from experts in academia, government and non-government organizations, and agricultural biotechnology developers from the private sector. A range of topics relevant to novel protein safety were discussed, including: the state of protein toxin biology, modes and mechanisms of action, structures and activity, use of bioinformatic analyses to assess the safety of a protein, and ways to leverage computational biology with in silico approaches for protein toxin identification/characterization. Key outcomes of the workshop included the appreciation of the complexity of developing a definition for a protein toxin when viewed from the perspective of food and feed safety, confirming the need for a case-by-case hypothesis-driven interpretation of bioinformatic results that leverages additional metadata rather than an alignment threshold-driven interpretation, and agreement that a "toxin protein database" is not necessary, as the bioinformatic needs for toxin detection may be accomplished by existing databases such as Pfam and UniProtKB/Swiss-Prot. In this paper, a path forward is proposed.


Assuntos
Biologia Computacional , Inocuidade dos Alimentos , Alérgenos/química , Alérgenos/toxicidade , Biotecnologia/métodos , Bases de Dados de Proteínas
2.
Regul Toxicol Pharmacol ; 79: 149-155, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27105772

RESUMO

Genetically modified (GM) crops have achieved success in the marketplace and their benefits extend beyond the overall increase in harvest yields to include lowered use of insecticides and decreased carbon dioxide emissions. The most widely grown GM crops contain gene/s for targeted insect protection, herbicide tolerance, or both. Plant expression of Bacillus thuringiensis (Bt) crystal (Cry) insecticidal proteins have been the primary way to impart insect resistance in GM crops. Although deemed safe by regulatory agencies globally, previous studies have been the basis for discussions around the potential immuno-adjuvant effects of Cry proteins. These studies had limitations in study design. The studies used animal models with extremely high doses of Cry proteins, which when given using the ig route were co-administered with an adjuvant. Although the presumption exists that Cry proteins may have immunostimulatory activity and therefore an adjuvanticity risk, the evidence shows that Cry proteins are expressed at very low levels in GM crops and are unlikely to function as adjuvants. This conclusion is based on critical review of the published literature on the effects of immunomodulation by Cry proteins, the history of safe use of Cry proteins in foods, safety of the Bt donor organisms, and pre-market weight-of-evidence-based safety assessments for GM crops.


Assuntos
Proteínas de Bactérias/genética , Qualidade de Produtos para o Consumidor , Produtos Agrícolas/genética , Endotoxinas/genética , Inocuidade dos Alimentos , Proteínas Hemolisinas/genética , Insetos/crescimento & desenvolvimento , Controle Biológico de Vetores/métodos , Plantas Geneticamente Modificadas/genética , Animais , Toxinas de Bacillus thuringiensis , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/metabolismo , Produtos Agrícolas/imunologia , Produtos Agrícolas/metabolismo , Produtos Agrícolas/parasitologia , Endotoxinas/imunologia , Endotoxinas/metabolismo , Regulação da Expressão Gênica de Plantas , Genótipo , Proteínas Hemolisinas/imunologia , Proteínas Hemolisinas/metabolismo , Interações Hospedeiro-Parasita , Humanos , Insetos/metabolismo , Fenótipo , Plantas Geneticamente Modificadas/imunologia , Plantas Geneticamente Modificadas/metabolismo , Plantas Geneticamente Modificadas/parasitologia , Medição de Risco
3.
Crit Rev Toxicol ; 43 Suppl 2: 25-42, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24164515

RESUMO

This manuscript focuses on the toxicological evaluation of proteins introduced into GM crops to impart desired traits. In many cases, introduced proteins can be shown to have a history of safe use. Where modifications have been made to proteins, experience has shown that it is highly unlikely that modification of amino acid sequences can make a non-toxic protein toxic. Moreover, if the modified protein still retains its biological function, and this function is found in related proteins that have a history of safe use (HOSU) in food, and the exposure level is similar to functionally related proteins, then the modified protein could also be considered to be "as-safe-as" those that have a HOSU. Within nature, there can be considerable evolutionary changes in the amino acid sequence of proteins within the same family, yet these proteins share the same biological function. In general, food crops such as maize, soy, rice, canola etc. are subjected to a variety of processing conditions to generate different food products. Processing conditions such as cooking, modification of pH conditions, and mechanical shearing can often denature proteins in these crops resulting in a loss of functional activity. These same processing conditions can also markedly lower human dietary exposure to (functionally active) proteins. Safety testing of an introduced protein could be indicated if its biological function was not adequately characterized and/or it was shown to be structurally/functionally related to proteins that are known to be toxic to mammals.


Assuntos
Alimentos Geneticamente Modificados/toxicidade , Plantas Geneticamente Modificadas/toxicidade , Proteínas/toxicidade , Sequência de Aminoácidos , Animais , Inocuidade dos Alimentos/métodos , Humanos , Proteínas de Plantas/química , Proteínas de Plantas/toxicidade , Proteínas/química , Medição de Risco/métodos , Testes de Toxicidade/métodos
4.
Front Allergy ; 2: 700533, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-35386979

RESUMO

Motivation: The availability of databases identifying allergenic proteins via a transparent and consensus-based scientific approach is of prime importance to support the safety review of genetically-modified foods and feeds, and public safety in general. Over recent years, screening for potential new allergens sequences has become more complex due to the exponential increase of genomic sequence information. To address these challenges, an international collaborative scientific group coordinated by the Health and Environmental Sciences Institute (HESI), was tasked to develop a contemporary, adaptable, high-throughput process to build the COMprehensive Protein Allergen REsource (COMPARE) database, a publicly accessible allergen sequence data resource along with bioinformatics analytical tools following guidelines of FAO/WHO and CODEX Alimentarius Commission. Results: The COMPARE process is novel in that it involves the identification of candidate sequences via automated keyword-based sorting algorithm and manual curation of the annotated sequence entries retrieved from public protein sequence databases on a yearly basis; its process is meant for continuous improvement, with updates being transparently documented with each version; as a complementary approach, a yearly key-word based search of literature databases is added to identify new allergen sequences that were not (yet) submitted to protein databases; in addition, comments from the independent peer-review panel are posted on the website to increase transparency of decision making; finally, sequence comparison capabilities associated with the COMPARE database was developed to evaluate the potential allergenicity of proteins, based on internationally recognized guidelines, FAO/WHO and CODEX Alimentarius Commission.

7.
Sci Rep ; 7(1): 13940, 2017 10 24.
Artigo em Inglês | MEDLINE | ID: mdl-29066768

RESUMO

Proteins are fundamental to life and exhibit a wide diversity of activities, some of which are toxic. Therefore, assessing whether a specific protein is safe for consumption in foods and feeds is critical. Simple BLAST searches may reveal homology to a known toxin, when in fact the protein may pose no real danger. Another challenge to answer this question is the lack of curated databases with a representative set of experimentally validated toxins. Here we have systematically analyzed over 10,000 manually curated toxin sequences using sequence clustering, network analysis, and protein domain classification. We also developed a functional sequence signature method to distinguish toxic from non-toxic proteins. The current database, combined with motif analysis, can be used by researchers and regulators in a hazard screening capacity to assess the potential of a protein to be toxic at early stages of development. Identifying key signatures of toxicity can also aid in redesigning proteins, so as to maintain their desirable functions while reducing the risk of potential health hazards.


Assuntos
Biologia Computacional , Proteínas/metabolismo , Toxinas Biológicas/metabolismo , Sequência de Aminoácidos , Análise por Conglomerados , Bases de Dados de Proteínas , Ordem dos Genes , Modelos Moleculares , Domínios Proteicos , Proteínas/química , Risco , Toxinas Biológicas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA